Haoxi Health Reports Massive Net Loss, Significant Asset Write-Downs, and Extreme Share Dilution
HAO sits 32% above its 52-week low of $0.82 on elevated volume (8.4× avg).
Summary
Haoxi Health reported a massive net loss driven by significant credit losses and asset impairment, alongside extreme share dilution from recent offerings, highlighting severe financial strain and ongoing liquidity challenges.
Key Events · Earnings and Guidance · HAO
-
Massive Net Loss Reported
The company's net loss surged to $6.88 million for the six months ended December 31, 2025, a significant increase from $0.23 million in the prior year period.
-
Significant Asset Write-Downs
General and administrative expenses spiked by 1308%, primarily due to a $6.02 million allowance for credit losses on prepaid expenses and third-party loans, and a $0.90 million impairment loss on intangible assets.
-
Extreme Share Dilution
Class A ordinary shares outstanding increased from 2.2 million to 58.75 million, a substantial increase resulting from recent follow-on offerings and share exchange agreements that raised $6.2 million.
-
Related Party Loan to CEO
A fund transfer of $1 million to CEO Zhen Fan was noted as an amount due from a related party, raising potential governance concerns.
Analysis · HAO · Trade & Services
Haoxi Health Technology Ltd. reported a substantial increase in net loss to $6.88 million for the six months ended December 31, 2025, compared to a $0.23 million loss in the prior year. This significant deterioration was primarily driven by a 1308% surge in general and administrative expenses, which included a $6.02 million allowance for credit losses on prepaid online advertising expenses and third-party loans. Additionally, the company recognized a $0.90 million impairment loss on intangible assets due to external market fluctuations and internal operational changes. Despite a 41% increase in revenue and an improved gross margin, the company's financial health remains precarious, marked by ongoing negative operating cash flows. The period also saw extreme share dilution, with Class A ordinary shares outstanding increasing from 2.2 million to 58.75 million, largely due to recent follow-on offerings and share exchanges that raised $6.2 million. The company's cash position decreased, and it anticipates continued negative operating cash flows, indicating an ongoing need for external financing. A related party transaction involving a $1 million fund transfer to CEO Zhen Fan also raises governance concerns.
At the time of this filing, HAO was trading at $1.08 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $68.4M. The 52-week trading range was $0.82 to $2.31. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.